Search
Add filters:
Use filters to refine the search results.
Item hits:
Issue Date | Title | Author(s) |
---|---|---|
2010 | Expression of mTOR and downstream signalling components in the JEG-3 and BeWo human placental choriocarcinoma cell lines | Mparmpakas, D; Zachariades, E; Foster, H; Kara, A; Harvey, AJ; Goumenou, A; Karteris, E |
2010 | Congenital imperforate hymen with hydrocolpos and hydronephrosis associated with severe hydramnios and increase of maternal ovarian steroidogenic enzymes | Karteris, E; Foster, H; Karamouti, M; Goumenou, A |
2011 | Expression of membrane and nuclear progesterone receptors in two human placental choriocarcinoma cell lines (JEG-3 and BeWo): Effects of syncytialization | Zachariades, E; Foster, H; Goumenou, A; Thomas, P; Rand-Weaver, M; Karteris, E |
2018 | Prognostic value of the DNA integrity index in patients with malignant lung tumors | Chudasama, DY; Aladag, Z; Felicien, MI; Hall, M; Beeson, J; Asadi, N; Gidron, Y; Karteris, E; Anikin, VB |
2018 | Involvement of the glutamine RF-amide peptide (QRFP) and its cognate receptor GPR103 in prostate cancer | Karteris, E; Kawan, M; Kyrou, I; Ramanjaneya, M; Williams, K; Jeyaneethi, J; Randeva, H |
2018 | Functional Cardiac Orexin Receptors: Role of Orexin-B/Orexin 2 Receptor in Myocardial Protection. | Karteris, E; Patel, VH; Chen, J; Kyrou, I; Mattu, H; Dimitriadis, G; Rodrigo, G; Antoniades, C; Antonopoulos, A; Tan, B; Hillhouse, E; Ng, A; Randeva, H |
7-Mar-2019 | Liquid biopsies in lung cancer: Four emerging technologies and potential clinical applications | Chudasama, D; Katopodis, P; Stone, N; Haskell, J; Sheridan, H; Gardner, B; Urnovitz, H; Schuetz, E; Beck, J; Hall, M; Barr, J; Sisu, C; Rice, A; Polychronis, A; Anikin, V; Karteris, E |
2016 | Differential effects of rapalogues, dual kinase inhibitors on human ovarian carcinoma cells in vitro | Rogers-Broadway, KR; Chudasama, D; Pados, G; Tsolakidis, D; Goumenou, A; Hall, M; Karteris, E |
9-Jun-2017 | Perioperative detection of circulating tumour cells in patients with lung cancer | Chudasama, D; Burnside, N; Beeson, J; Karteris, E; Rice, A; Anikin, V |
12-Sep-2019 | Kinase inhibitors and ovarian cancer | Katopodis, P; Chudasama, D; Wander, G; Sales, L; Kumar, J; Pandhal, M; Anikin, V; Chatterjee, J; Hall, M; Karteris, E |
Discover
Subject
- 15 ovarian cancer
- 6 mTOR
- 4 biomarker
- 4 BPA
- 3 COVID-19
- 3 Lung cancer
- 3 lung cancer
- 3 Ovarian cancer
- 2 2D
- 2 3D
- next >
Date issued
- 39 2020 - 2024
- 28 2010 - 2019